Compared to patients without HT, those in the HT group exhibited significant differences in several parameters, including age, blood glucose levels, admission NIHSS, ASPECTS, NLR, atrial fibrillation, coronary heart disease, anticoagulant therapy, diabetes, previous smoking, TOAST classification, SBP, HbA1c, eosinophils, albumin, CRP, and triglycerides (p < 0.05). This evidence concerns the gene ALB and atrial fibrillation.